Clinical Trials in Boston

Showing 7001-7020 of 13,548 trials

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

NCT00125099

The purpose of this study is to evaluate whether the HIV vaccine VRC-HIVDNA009-00-VP will be safe in individuals who started antiretroviral therapy during acute HIV-1 infection. The study will also test whether the vaccine can increase the immune system function in these participants.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)21 participants

San Diego, California, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDPhase 1/2< 1 mile

Adding New Drugs for HIV Infected Patients Failing Current Therapy

NCT00031044

Even though powerful anti-HIV drug combinations have been successful in patients with little or no prior anti-HIV therapy, studies have shown that these treatments are less effective in patients who have been treated with nucleoside analogues. This study will test the safety and effectiveness of adding one or two new drugs to a personalized anti-HIV regimen for patients whose previous HIV treatments have failed.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)50 participants

Denver, Colorado, United States • Miami, Florida, United States • Boston, Massachusetts, United States +6 more locations

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

Adding New Drugs for HIV Infected Patients Failing Current Therapy

Find Trials by Condition in Boston

Efficacy of Continuous Glucose Monitoring in Neonates With Hypoglycemia

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)

A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia

A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss

Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

A Study of HIV-Disease Development in Aging

A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection

A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)

Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel

Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV

A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.

Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age